Prospera Financial Services’s Sarepta Therapeutics SRPT Stock Holding History

Prospera Financial Services’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$306K	Sell	17,042 -450	-3%	-$8.51K	﹤0.01%	1228
2026 Q1	$381K	Buy	17,492 +3,400	+24%	+$65.8K	0.01%	1110
2025 Q4	$303K	Sell	14,092 -475	-3%	-$10K	0.01%	1149
2025 Q3	$281K	Buy	+14,567	New	+$260K	﹤0.01%	1167
2022 Q2	–	Sell	-162	Closed	-$13K	–	2490
2022 Q1	$13K	Buy	+162	New	+$12.4K	﹤0.01%	1929
2021 Q1	–	Sell	-1,471	Closed	-$251K	–	776
2020 Q4	$251K	Sell	1,471 -148	-9%	-$21.9K	0.02%	585
2020 Q3	$227K	Sell	1,619 -395	-20%	-$60K	0.09%	205
2020 Q2	$323K	Sell	2,014 -625	-24%	-$85.1K	0.03%	424
2020 Q1	$258K	Sell	2,639 -620	-19%	-$70.9K	0.03%	426
2019 Q4	$421K	Buy	+3,259	New	+$329K	0.03%	412

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Prospera Financial Services's SRPT Position: Q2 2026 in Review

Prospera Financial Services reduced its Sarepta Therapeutics (SRPT) stake by 2.6% in Q2 2026, selling an estimated $8.51K and leaving 17,042 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #1228.

Prospera Financial Services first reported a position in SRPT in Q4 2019 and has held it in 10 quarters since. The position peaked at $421K in Q4 2019. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Prospera Financial Services held 17,042 shares of Sarepta Therapeutics worth $306K as of Q2 2026.
Prospera Financial Services sold 450 Sarepta Therapeutics shares in Q2 2026, an estimated $8.51K.
Sarepta Therapeutics made up ﹤0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1228 holding.
Prospera Financial Services first reported a position in Sarepta Therapeutics in Q4 2019 and has held it in 10 quarters since.
Prospera Financial Services's Sarepta Therapeutics position peaked at $421K in Q4 2019.
324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.